Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
Matinas BioPharma Holdings reports 2018 executive compensation
By ExecPay News
Published: September 24, 2019
Matinas BioPharma Holdings reported fiscal year 2018 executive compensation information on September 24, 2019.
In 2018, four executives at Matinas BioPharma Holdings received on average a compensation package of $548K, a 49% decrease compared to previous year.
Average pay of disclosed executives at Matinas BioPharma Holdings
Jerome D. Jabbour, Chief Executive Officer, received $1.3M in total, which decreased by 1% compared to 2017. 64.10% of Jabbour's compensation, or $804.3K, was in option awards. Jabbour also received $84K in bonus and $366.5K in salary.
Roelof Rongen, Chief Executive Officer, received a compensation package of $400K, which decreased by 79% compared to previous year. 54.17% of the compensation package, or $216.7K, was in other compensation.
Raphael Mannino, Chief Scientific Officer, earned $294.6K in 2018, a 50% decrease compared to previous year.
Gary Gaglione, Chief Financial Officer, received $242.6K in 2018, which decreases by 55% compared to 2017.
Related executives
You may also like
Source: SEC filing on September 24, 2019.